Organization | Ayub Medical College, Abbottabad

Ayub Medical College, Abbottabad Report issue

Academic/Hospital Phase 3 Phase 4

Organization Overview

First Clinical Trial

2016

NCT05467384

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2022

Timeline

NOW

Now

Alternative names

Ayub Medical College, Abbottabad | Ayub Teaching Hospital | Ayub Teaching Hospital, ABbottabad

Active Ingredients

Drugs in Phase 4 Trials (1)

amlodipine (norvasc) (2 trials)

Drugs in Phase 3 Trials (4)

azithromycin (zithromax) (1 trial)

colchicine (colbenemid) (1 trial)

glucose (1 trial)

hydroxychloroquine (plaquenil) (1 trial)

Drugs in Other Trials (5)

atorvastatin (lipitor) (1 trial)

curcumin (1 trial)

lemon (1 trial)

quercetin (1 trial)

vitamin d3 (1 trial)

Indications

Overview

Highest Phase: Phase 4
# of Trials: 6
# of Trial APIs: 10